DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Pipeline Advances FITBO Q1 2026 Earnings Earnings Surpass Estimates by 35 MCHPP Q1 2026 Earnings Strong Earnings Beat Drives Positive Market Response Recursion Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Pipeline Progress CubeSmart CUBE Q1 2026 Earnings EPS Beats Estimates Amid Stable Operations CLLS Q1 2026 Earnings Narrowing Losses as Cost Discipline Surprises to the Upside